CCL2 and metabolic dysfunction-associated steatohepatitis: Subjects with NASH had significantly higher fasting circulating levels of TNF-α (p < 0.0001), hs-CRP (p < 0.05), IL-6 (p < 0.05) and CCL-2 (p < 0.05) than controls (Figure 5).